Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Qld, Australia.
Faculty of Medicine and Faulty of Health and Behavioural Sciences, University of Queensland, Brisbane, Qld, Australia.
Aliment Pharmacol Ther. 2020 Jul;52(1):155-167. doi: 10.1111/apt.15786. Epub 2020 May 15.
Small intestinal bacterial overgrowth may play a role in gastrointestinal and non-gastrointestinal diseases.
To use quantitative polymerase chain reaction (qPCR) to determine and compare bacterial loads of duodenal biopsies in asymptomatic controls, and patients with functional gastrointestinal disorders (FGIDs) and inflammatory bowel disease (IBD) including ulcerative colitis (UC) and Crohn's disease (CD). To define effects of gastric acid inhibition on bacterial load, explore links of bacterial load and gastrointestinal symptoms in response to a standardised nutrient challenge and compare bacterial load with glucose breath test results.
In 237 patients (63 controls, 84 FGID and 90 IBD), we collected mucosal samples under aseptic conditions during endoscopy extracted and total DNA. Bacterial load metric was calculated utilising qPCR measurements of the bacterial 16S rRNA gene, normalised to human beta-actin expression. Standard glucose breath test and nutrient challenge test were performed.
The duodenal microbial load was higher in patients with FGID (0.22 ± 0.03) than controls (0.07 ± 0.05; P = 0.007) and patients with UC (0.01 ± 0.05) or CD (0.02 ± 0.09), (P = 0.0001). While patients treated with proton pump inhibitors (PPI) had significantly higher bacterial loads than non-users (P < 0.05), this did not explain differences between patient groups and controls. Bacterial load was significantly (r = 0.21, P < 0.016) associated with the symptom response to standardised nutrient challenge test. Methane, but not hydrogen values on glucose breath test were associated with bacterial load measured utilising qPCR.
Utilising qPCR, a diagnosis of FGID and treatment with PPI were independently associated with increased bacterial loads. Increased bacterial loads are associated with an augmented symptom response to a standardised nutrient challenge.
小肠细菌过度生长可能在胃肠道和非胃肠道疾病中发挥作用。
使用定量聚合酶链反应(qPCR)来确定和比较无症状对照者、功能性胃肠病(FGID)和炎症性肠病(IBD)患者(包括溃疡性结肠炎[UC]和克罗恩病[CD])十二指肠活检的细菌负荷。确定胃酸抑制对细菌负荷的影响,探讨细菌负荷与胃肠道症状之间的联系,以响应标准化营养挑战,并将细菌负荷与葡萄糖呼气试验结果进行比较。
在 237 名患者(63 名对照者、84 名 FGID 和 90 名 IBD)中,我们在无菌条件下收集内窥镜检查期间的粘膜样本,提取并提取总 DNA。使用细菌 16S rRNA 基因的 qPCR 测量值,归一化为人类β-肌动蛋白表达,计算细菌负荷指标。进行标准葡萄糖呼气试验和营养挑战试验。
FGID 患者的十二指肠微生物负荷高于对照组(0.22±0.03 比 0.07±0.05;P=0.007)和 UC(0.01±0.05)或 CD(0.02±0.09)患者(P=0.0001)。虽然接受质子泵抑制剂(PPI)治疗的患者的细菌负荷明显高于非使用者(P<0.05),但这并不能解释患者组与对照组之间的差异。细菌负荷与标准化营养挑战试验的症状反应显著相关(r=0.21,P<0.016)。葡萄糖呼气试验中甲烷,但不是氢值与 qPCR 测量的细菌负荷相关。
使用 qPCR,FGID 的诊断和 PPI 的治疗与细菌负荷的增加独立相关。细菌负荷增加与标准化营养挑战的症状反应增强相关。